FDA Investigator Robert W Hudson
Robert W Hudson has conducted inspections on 117 sites in 1 countries as of 08 Apr 2004. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
117
Last Inspection Date:
08 Apr 2004
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Robert W Hudson:
Allison C Hunter,
Amanda M Osteen,
Andrew I Carr,
Andrew M Kupper,
Anetra E Wyatt,
Arie R Dyk,
Bailey A Uetrecht,
Benjamin D Motsinger,
Brenda C Hamilton,
Bryan J Love,
Cassandra L Winters,
Charvais S Hill,
Christian L Witkovskie,
Christine E Kelley,
Christopher T Middendorf,
Cody D Rickman,
Craig P Seaborn,
Craig Rybus,
Craig T Rybus,
David C Radle,
David P Moorhead,
Denise L Burosh,
Elizabeth L Loreaux,
Elizabeth Ll Edwards,
Elizabeth P Kinsella,
Eric R Holm,
Erica N Sandoval,
Fabian Nchaparro Rodriguez,
Felipe Rde Almeida,
Holly J Rapier,
Holly J Wilson,
Holly L Miller,
James G Marsh,
Jamie L Johnson,
Jason D Werne,
Javonica F Penn,
Jennifer L Sheehan,
Jennifer M Heitz,
John D Jaworski,
John E Russell, Jr,
Jonathan A Ferguson,
Karen M Cooper,
Kathleen D Culver,
Kathryn J Mccarty,
Kerry Ann Latham,
Krista T Ferry,
Laressa R Gray,
Lauren R Collins,
Leena Thomas,
Lindsey M Schwierjohann,
Luckner Jean Marie,
Marianne Allen,
Maribeth G Niesen,
Matt D Suedkamp,
Matthew H Pitts,
Matthew J Zagula,
Michael E Campbell,
Michael J Schibi,
Michelle L Jones,
Nicholas L Paulin,
Nicholas Paulin,
Pamela A Kuist,
Patricia A Borrusso,
Patricia A Homola,
Paul M Chefor,
Payne,
Philip S Woodward,
Pifer,
Roy C Stephens,
Samuel A Hamblin,
Sandricka M Mosley,
Stephen J Rabe,
Susan M Taylor,
Talmane J Fisher,
Tamara M Kays,
Thomas C Woods,
Thomas J Prigge,
Thomas O Morgan,
Thomas W Nojek,
Thunder N Dunkijacobs,
Tracey L Harris,
Troy A Huffman,
William K Ducloux
Robert W Hudson's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2000 | EIR | Kentucky Pediatric Research - EIR, 2000-01-06 |
August, 2003 | EIR | Western Kentucky Regional Blood Ctr - EIR, 2003-08-29 |
August, 2003 | FDA 483 | BET Pharm LLC - Form 483, 2003-08-06 |
October, 2002 | EIR | Kentucky Organ Donor Affiliates, Inc. - EIR, 2002-10-23 |
May, 2000 | EIR | KOBY KARP DOCTORS EYE INSTITUTE - EIR, 2000-05-10 |
July, 2000 | EIR | Thomas Moran MD - EIR, 2000-07-26 |
May, 2000 | EIR | Robert Fechtner MD - EIR, 2000-05-19 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more